Form 4: Thermo Fisher SVP Sells Shares for Tax Obligations

Sentiment:

Insider Transaction Report


Thermo Fisher Scientific's SVP and General Counsel, Thomas B. Shropshire Jr., disposed of 337.476 shares of common stock to cover tax withholding obligations.

Summary

  • Thomas B. Shropshire Jr., SVP and General Counsel of Thermo Fisher Scientific Inc. (TMO), reported a transaction involving company common stock.
  • On December 2, 2025, Shropshire disposed of 337.476 shares of common stock.
  • The disposition was made at a price of $580.37 per share, totaling approximately $195,860.09.
  • This transaction was coded 'F', indicating a disposition to the issuer to satisfy tax withholding obligations.
  • Following this transaction, Shropshire beneficially owns 5,079.524 shares of Thermo Fisher Scientific common stock directly.

Sentiment

Score: 5

Explanation: The filing reports a routine insider transaction for tax withholding purposes, which is neutral in sentiment and does not indicate any significant positive or negative developments for the company.

Future Outlook

NA

Industry Context

This is a routine insider transaction for tax withholding purposes and does not reflect broader industry trends or competitive positioning for Thermo Fisher Scientific.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Power of Attorney AuthorizationThomas B. Shropshire Jr. authorized Julia L. Chen, Kylie S. Herring, and Melodie T. Morin to execute and file SEC Forms 3, 4, and 5 on his behalf.2025-11-12This is a standard corporate governance practice to facilitate timely and accurate SEC filings for executives, ensuring compliance with Section 16(a) of the Securities Exchange Act of 1934.

Stakeholder Impact

  • Shareholders: Minimal direct impact as this is a routine, non-discretionary transaction for tax purposes by an executive, not indicative of a change in confidence or company fundamentals.
  • Employees: No direct impact.

Key Dates

DateDescription
2025-11-12Date of Power of Attorney authorizing individuals to execute and file SEC Forms 3, 4, and 5 on behalf of Thomas B. Shropshire Jr.
2025-12-02Date of transaction where Thomas B. Shropshire Jr. disposed of common stock.
2025-12-03Date the Form 4 was signed by the attorney-in-fact.

Keywords

Thermo Fisher Scientific, TMO, Insider Trading, Form 4, Stock Sale, Tax Withholding, Executive Compensation

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.